Rivastigmine: a review
- PMID: 10656066
- DOI: 10.12968/hosp.1999.60.10.1217
Rivastigmine: a review
Abstract
The acetylcholinesterase inhibitors are the first useful and useable drugs for palliative treatment of dementia of the Alzheimer type. This article reviews the second-generation carbamate cholinesterase inhibitor, rivastigmine (EXELON, Novartis, Basel) whose distinctive pharmacology is not only of immediate clinical relevance but also the key to some tantalizing therapeutic possibilities.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical